AI-generated summary
This review proposes that low-level laser therapy may attenuate the cytokine storm and pulmonary inflammation seen in COVID-19 and could be combined with conventional treatment. The authors base this on prior meta-analyses, clinical experience, peer-reviewed studies and experimental animal models. The abstract presents these as possibilities rather than demonstrated outcomes in COVID-19 patients.
- Who or what was studied
- COVID-19 patients with ARDS and cytokine storm, drawing on meta-analyses, clinical experience, and animal models
- Limits stated in the abstract
- The abstract describes a narrative summary and proposed protocol, with no stated clinical trial data in COVID-19 patients and no reported study count.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on cjrt.ca.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Wound healing, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.